| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 呼吸系统药物(元) | 634,786,826.06 | 1,140,350,332.73 | 536,261,209.44 | 932,692,468.42 | 407,162,158.58 |
| 全身用抗感染药物(元) | 73,305,406.13 | 146,634,498.84 | 73,370,361.39 | 127,789,582.60 | 62,786,264.55 |
| 消化系统药物(元) | 67,491,281.19 | 400,143,610.92 | 203,458,327.58 | 362,118,060.48 | 221,365,943.94 |
| 其它药物(元) | 46,537,785.74 | 218,053,720.53 | 87,159,185.68 | 92,446,342.12 | 42,144,361.87 |
| 原料药(元) | 24,592,806.91 | - | 13,730,238.91 | - | - |
| 营业成本(元) | |||||
| 呼吸系统药物(元) | 317,076,217.68 | 593,879,496.06 | - | 427,940,453.26 | - |
| 全身用抗感染药物(元) | 44,375,084.14 | 88,185,172.22 | - | 70,163,398.38 | - |
| 消化系统药物(元) | 22,589,858.27 | 123,033,769.14 | - | 101,055,157.66 | - |
| 其它药物(元) | 20,051,206.00 | 94,733,696.86 | - | 39,423,310.00 | - |
| 原料药(元) | 14,042,347.70 | - | - | - | - |
| 毛利(元) | |||||
| 呼吸系统药物(元) | 317,710,608.38 | 546,470,836.67 | - | 504,752,015.16 | - |
| 全身用抗感染药物(元) | 28,930,321.99 | 58,449,326.62 | - | 57,626,184.22 | - |
| 消化系统药物(元) | 44,901,422.92 | 277,109,841.78 | - | 261,062,902.82 | - |
| 其它药物(元) | 26,486,579.74 | 123,320,023.67 | - | 53,023,032.12 | - |
| 原料药(元) | 10,550,459.21 | - | - | - | - |
| 毛利率(%) | |||||
| 呼吸系统药物(%) | 50.05 | 47.92 | - | 54.12 | - |
| 全身用抗感染药物(%) | 39.47 | 39.86 | - | 45.09 | - |
| 消化系统药物(%) | 66.53 | 69.25 | - | 72.09 | - |
| 其它药物(%) | 56.91 | 56.55 | - | 57.36 | - |
| 原料药(%) | 42.90 | - | - | - | - |
| 收入构成(%) | |||||
| 呼吸系统药物(%) | 74.97 | 59.86 | 58.67 | 61.56 | 55.51 |
| 全身用抗感染药物(%) | 8.66 | 7.70 | 8.03 | 8.43 | 8.56 |
| 消化系统药物(%) | 7.97 | 21.00 | 22.26 | 23.90 | 30.18 |
| 其它药物(%) | 5.50 | 11.45 | 9.54 | 6.10 | 5.75 |
| 原料药(%) | 2.90 | - | 1.50 | - | - |
| 毛利构成(%) | |||||
| 呼吸系统药物(%) | 74.13 | 54.36 | - | 57.59 | - |
| 全身用抗感染药物(%) | 6.75 | 5.81 | - | 6.57 | - |
| 消化系统药物(%) | 10.48 | 27.56 | - | 29.79 | - |
| 其它药物(%) | 6.18 | 12.27 | - | 6.05 | - |
| 原料药(%) | 2.46 | - | - | - | - |